company background image
RHHB.F logo

Roche Holding OTCPK:RHHB.F Stock Report

Last Price

US$251.53

Market Cap

US$201.8b

7D

-8.0%

1Y

-15.0%

Updated

26 Mar, 2024

Data

Company Financials +

RHHB.F Stock Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania.

RHHB.F fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance4/6
Financial Health4/6
Dividends3/6

Roche Holding AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Roche Holding
Historical stock prices
Current Share PriceCHF251.53
52 Week HighCHF354.00
52 Week LowCHF251.53
Beta0.15
1 Month Change-10.17%
3 Month Change-19.38%
1 Year Change-15.02%
3 Year Change-27.09%
5 Year Change-7.24%
Change since IPO101.22%

Recent News & Updates

Recent updates

Shareholder Returns

RHHB.FUS PharmaceuticalsUS Market
7D-8.0%-0.2%0.6%
1Y-15.0%23.9%29.5%

Return vs Industry: RHHB.F underperformed the US Pharmaceuticals industry which returned 23.1% over the past year.

Return vs Market: RHHB.F underperformed the US Market which returned 29.8% over the past year.

Price Volatility

Is RHHB.F's price volatile compared to industry and market?
RHHB.F volatility
RHHB.F Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: RHHB.F's share price has been volatile over the past 3 months.

Volatility Over Time: RHHB.F's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1896103,605Thomas Schineckerhttps://www.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas.

Roche Holding AG Fundamentals Summary

How do Roche Holding's earnings and revenue compare to its market cap?
RHHB.F fundamental statistics
Market capUS$201.82b
Earnings (TTM)US$12.72b
Revenue (TTM)US$66.85b

15.8x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHHB.F income statement (TTM)
RevenueCHF60.44b
Cost of RevenueCHF15.60b
Gross ProfitCHF44.84b
Other ExpensesCHF33.35b
EarningsCHF11.50b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)14.42
Gross Margin74.19%
Net Profit Margin19.02%
Debt/Equity Ratio88.0%

How did RHHB.F perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

67%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.